Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: RTOG 1203 - A Randomized Phase III Study Of Standard Vs. IMRT Pelvic Radiation For Post-Operative Treatment Of Endometrial And Cervical Cancer (TIME-C)--RTOG CCOP Study

 


RTOG 1203 - A Randomized Phase III Study Of Standard Vs. IMRT Pelvic Radiation For Post-Operative Treatment Of Endometrial And Cervical Cancer (TIME-C)--RTOG CCOP Study


Trial Focus

Female Reproductive Cancer

Objective

         This is a clinical trial of intensity-modulated radiation therapy (IMRT) compared to standard radiation techniques and is standard of care.

IRB Protocol #

13-2453

Trial Status

OPEN

Principle Investigator

CHRISTINE FISHER

Sponsor

RTOG

Contact

MONICA ROBISCHON at (720) 848-0661 or MONICA.ROBISCHON@UCDENVER.EDU

Location

University of Colorado Hospital University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : A screening period to determine eligibility. A treatment period(s) that can last up to 5-6 weeks. A follow up period will consist of visits scheduled 4-6 weeks after completion of your radiation therapy, and then every 6 months during years 1 and 2 from the start of your radiation therapy and then once every year for 8 years for a total of 10 years. // Eligibility criteria include but are not limited to women 18 years or older with endometrial and cervical cancer.Eligibility criteria include but are not limited to women 18 years or older with endometrial and cervical cancer.